[Risk Factors and Prognosis of Secondary Epilepsy in Children with Viral Encephalitis]

Liang Huang1,2, Dan Yu3, Rong Luo3

  • 1Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China.

Insights

Pediatric viral encephalitis can lead to epilepsy, with risk factors including repetitive seizures and mental/behavior disorders. Early detection and management are crucial for better outcomes in children with post-viral encephalitic epilepsy.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Epileptology

Background:

  • Viral encephalitis is a significant cause of neurological morbidity in children.
  • Post-infectious epilepsy, particularly post-viral encephalitic epilepsy, presents unique challenges in diagnosis and management.
  • Understanding the acute clinical features associated with the development of epilepsy is crucial for timely intervention.

Purpose of the Study:

  • To investigate the clinical features of viral encephalitis in children during the acute stage.
  • To identify the relationship between these clinical features and the subsequent development of post-viral encephalitic epilepsy.
  • To analyze risk factors for the occurrence, control, and prognosis of post-viral encephalitic epilepsy.

Main Methods:

  • A cohort of 506 children diagnosed with viral encephalitis was retrospectively analyzed.
  • Clinical data, including general condition, manifestations, video electroencephalogram (VEEG), neuroimaging, and virology, were collected.
  • Logistic regression was used to determine risk factors for epilepsy development, seizure control, and prognosis.

Main Results:

  • 11.46% of children developed epilepsy after a follow-up of over 1.5 years.
  • Risk factors for epilepsy included repetitive seizures, detected clinical seizures on EEG, status epilepticus, and mental/behavior disorders.
  • While 74.07% of epilepsy cases had favorable seizure control, 41.38% had a poor prognosis, with intellectual and psychomotor retardation being common.

Conclusions:

  • Mental/behavior disorders, repetitive seizures, status epilepticus, and EEG-detected seizures are significant risk factors for developing post-viral encephalitic epilepsy in children.
  • The specific risk factors contributing to a poor prognosis in these cases require further investigation.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
60